The Law Offices of Vincent Wong are investigating potential claims
against the Board of Directors of Auspex Pharmaceuticals Inc. (Nasdaq:
ASPX) (“Auspex Pharmaceuticals” or “the Company”) in connection with the
sale of the Company to Teva Pharmaceutical Industries Ltd.
Click here to learn about the case: http://docs.wongesq.com/ASPX-Info-Request-Form-665.
There is no cost or obligation to you.
Under the terms of the transaction, Auspex Pharmaceuticals shareholders
will receive $101 in cash for each share of Auspex Pharmaceuticals stock
they own. The investigation concerns whether the Board of Auspex
Pharmaceuticals breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter into
this transaction, and whether Teva Pharmaceutical Industries Ltd. is
underpaying for Auspex Pharmaceuticals shares.
If you own common stock in Auspex Pharmaceuticals and wish to obtain
additional information, please contact Vincent Wong, Esq. either via
email vw@wongesq.com, by telephone
at 212.425.1140, or visit http://docs.wongesq.com/ASPX-Info-Request-Form-665.
Vincent Wong, Esq. is an experienced attorney that has represented
investors in securities litigations involving financial fraud and
violations of shareholder rights. Attorney advertising. Prior results do
not guarantee similar outcomes.
Copyright Business Wire 2015